Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa GlobeNewswire - Mon Jul 13, 6:02AM CDT

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestones Royalties equaling 22% of net sales Ocugen to manufacture and supply OCU400 MALVERN, Pa.,...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming July Industry Conferences GlobeNewswire - Wed Jul 1, 6:00AM CDT

MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming June Investor and Industry Conferences GlobeNewswire - Tue Jun 2, 6:03AM CDT

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes GlobeNewswire - Thu May 14, 3:30PM CDT

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming May Scientific and Investor Conferences GlobeNewswire - Wed May 13, 6:02AM CDT

MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen: Q1 Earnings Snapshot AP - Tue May 5, 7:40AM CDT

Ocugen: Q1 Earnings Snapshot

OCGN : 1.2600 (-2.33%)
Ocugen Provides Business Update with First Quarter 2026 Financial Results GlobeNewswire - Tue May 5, 7:32AM CDT

Conference Call and Webcast Today at 8:30 a.m. ET Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically significant (p

OCGN : 1.2600 (-2.33%)
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes GlobeNewswire - Tue May 5, 7:12AM CDT

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announced the pricing of $115 million aggregate principal amount of 6.75% Convertible Senior Notes due...

OCGN : 1.2600 (-2.33%)
Ocugen's Gene Therapy Timeline Finally Gets a Number Tomorrow Barchart - Mon May 4, 4:22PM CDT

Barchart Research What to Expect from OCGN Earnings OCGN Generated May 4, 2026 Current Price $1.8500 EPS Estimate $$-0.05 Consensus Rating Strong Buy Average Move 6.53% Ocugen's Gene Therapy Timeline Finally...

OCGN : 1.2600 (-2.33%)
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes GlobeNewswire - Mon May 4, 3:01PM CDT

MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...

OCGN : 1.2600 (-2.33%)

Barchart Exclusives

Oklo Joins Trump’s $200M Nuclear Push for AI. Here’s What It Means for OKLO Stock. Barchart - 21 minutes ago
Oklo energy joins President Donald Trump's administration to boost nuclear energy development. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.